Imaging of Multiple Myeloma

Barry Amos, Amit Agarwal, Sangam Kanekar

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Multiple myeloma is the most common bone malignancy. Imaging plays an important role in identifying the extent of the disease, disease process, guiding biopsies, and diagnosing associated spinal and intracranial complications. Multiple myeloma and related plasma cell proliferative disorders have a diverse set of clinicopathologic findings and on neuroimaging present unique and diverse findings from the disease and from complications of the disease and treatment, which are valuable for clinicians and radiologists.

Original languageEnglish (US)
Pages (from-to)843-865
Number of pages23
JournalHematology/Oncology Clinics of North America
Volume30
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Multiple Myeloma
Plasma Cells
Neuroimaging
Biopsy
Bone and Bones
Neoplasms
Therapeutics

Keywords

  • Classification
  • Complications
  • Imaging
  • Multiple myeloma
  • Treatment

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Imaging of Multiple Myeloma. / Amos, Barry; Agarwal, Amit; Kanekar, Sangam.

In: Hematology/Oncology Clinics of North America, Vol. 30, No. 4, 01.08.2016, p. 843-865.

Research output: Contribution to journalReview article

Amos, Barry ; Agarwal, Amit ; Kanekar, Sangam. / Imaging of Multiple Myeloma. In: Hematology/Oncology Clinics of North America. 2016 ; Vol. 30, No. 4. pp. 843-865.
@article{74a62cee10564df48a5465488941ea5e,
title = "Imaging of Multiple Myeloma",
abstract = "Multiple myeloma is the most common bone malignancy. Imaging plays an important role in identifying the extent of the disease, disease process, guiding biopsies, and diagnosing associated spinal and intracranial complications. Multiple myeloma and related plasma cell proliferative disorders have a diverse set of clinicopathologic findings and on neuroimaging present unique and diverse findings from the disease and from complications of the disease and treatment, which are valuable for clinicians and radiologists.",
keywords = "Classification, Complications, Imaging, Multiple myeloma, Treatment",
author = "Barry Amos and Amit Agarwal and Sangam Kanekar",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.hoc.2016.03.007",
language = "English (US)",
volume = "30",
pages = "843--865",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Imaging of Multiple Myeloma

AU - Amos, Barry

AU - Agarwal, Amit

AU - Kanekar, Sangam

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Multiple myeloma is the most common bone malignancy. Imaging plays an important role in identifying the extent of the disease, disease process, guiding biopsies, and diagnosing associated spinal and intracranial complications. Multiple myeloma and related plasma cell proliferative disorders have a diverse set of clinicopathologic findings and on neuroimaging present unique and diverse findings from the disease and from complications of the disease and treatment, which are valuable for clinicians and radiologists.

AB - Multiple myeloma is the most common bone malignancy. Imaging plays an important role in identifying the extent of the disease, disease process, guiding biopsies, and diagnosing associated spinal and intracranial complications. Multiple myeloma and related plasma cell proliferative disorders have a diverse set of clinicopathologic findings and on neuroimaging present unique and diverse findings from the disease and from complications of the disease and treatment, which are valuable for clinicians and radiologists.

KW - Classification

KW - Complications

KW - Imaging

KW - Multiple myeloma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84991257123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991257123&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2016.03.007

DO - 10.1016/j.hoc.2016.03.007

M3 - Review article

C2 - 27444000

AN - SCOPUS:84991257123

VL - 30

SP - 843

EP - 865

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 4

ER -